single

Tata Steel's consolidated net profit jumped 206.18% to Rs 3116.20 crore on 34.82% rise in total income to Rs 44175.53 crore in Q2 September 2018 over Q2 September 2017. The result was announced after market hours yesterday, 13 November 2018.

Sun Pharmaceuticals Industries reported consolidated net loss of Rs 108.84 crore in Q2 September 2018 as compared to net profit of Rs 1001.79 crore in Q2 September 2017. Total income rose 5.56% to Rs 7288.78 crore in Q2 September 2018 over Q2 September 2017. The result was announced after market hours yesterday, 13 November 2018.

Glenmark Pharmaceuticals' consolidated net profit advanced 93.35% to Rs 414 crore on 26.33% rise in total income to Rs 2888.39 crore in Q2 September 2018 over Q2 September 2017. The result was announced after market hours yesterday, 13 November 2018.

Ashok Leyland's net profit surged 37.49% to Rs 459.58 crore on 24.53% rise in total income to Rs 7636.13 crore in Q2 September 2018 over Q2 September 2017. The result was announced after market hours yesterday, 13 November 2018.

Sasken Technologies said that as a matter of abundant caution, the company has received an assessment order under Section 143(3) of the Income Tax Act, 1961 for the Assessment Year 2016-17 wherein a sum of about Rs 68 crore including interest was raised as tax demand on the company. However, the company stand by the position taken in the Income Tax Return filed for the year and is in the process of filing an appeal against the order. The announcement was made after market hours yesterday, 13 November 2018.

TAGS

0 thoughts on “Tata Steel Sun Pharma to react to Q2 results”

Post Comment


  High Accuracy Stock Future Performance

Performance given here is genuine and can check by taking pay or call trial, no free trial given to anybody as our trial calls are also worth to earn money and check us, you can even check without trading in trial period.

Get Intraday Tips / Delivery calls for FREE


View My Stats